Beijing Anzhen Hospital
Beijing, China
Location status: Recruiting
NCT Number: NCT05337319
The study will estimate the current status of care for participants with coronary artery disease
Interested in participating?
Request Info18 year and older
All sexes
Observational
Beijing, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Duration of hospital stay, an expected average of 1 week
Performance measures for CAD care including:
Proportion of patients received fibrinolytic therapy within 30 mins (STEMI) Proportion of patients received primary percutaneous coronary intervention within 90 mins (STEMI) Proportion of patients received reperfusion therapy (STEMI, high or moderate risk NSTE-ACS) Proportion of patients with aspirin prescribed at discharge Proportion of patients with P2Y12 inhibitors prescribed at discharge Proportion of patients with beta-blocker prescribed at discharge Proportion of patients with statin prescribed at discharge Proportion of left ventricular systolic dysfunction patients with ACEI or ARB prescribed at discharge Proportion of patients received evaluation of left ventricular systolic function Proportion of patients with a diagnosed non-obstructive coronary artery disease at discharge
Contact information is provided by the study sponsor or research team.
Shaoping Nie, MD, PhD
CONTACT
Yan Yan, MD
CONTACT
Beijing Anzhen Hospital
Other
A Multi-center, Prospective, Registry Study to Estimate the Current Status of Care for Patients With Coronary Artery Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06137521
Arterial Occlusive Diseases, Arteriosclerosis
Shanghai, China
View Trial DetailsNCT07771127
Arterial Occlusive Diseases, Arteriosclerosis
Bursa, Nilüfer, Turkey (Türkiye)
View Trial DetailsNCT07769008
Arterial Occlusive Diseases, Arteriosclerosis
Shanghai, China
View Trial DetailsNCT06578234
Arterial Occlusive Diseases, Arteriosclerosis
Lund, Sweden
View Trial Details